Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hellerup – page 60

1 458 clinical trials in Hellerup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hellerup at a glance
1 458
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 458 trials in Hellerup

Open in trial search

Pancreatic carcinoma

Not yet recruiting

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Colorectal cancer

Not yet recruiting

Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet

Polycythaemia vera

Not yet recruiting

Study on the Safety and Effectiveness of Peginterferon Alfa-2a and Ruxolitinib for Newly Diagnosed Polycythemia Vera Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Region Sjaelland

Adenocarcinoma pancreas

Not yet recruiting

Study on the Safety and Effectiveness of mFOLFIRINOX with or without BNT321 for Patients with Resected Pancreatic Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:BioNTech SE

Hip arthroplasty+1

Not yet recruiting

Study on Temporarily Stopping Duloxetine, Sertraline, and Paroxetine in Patients with Hip or Knee Osteoarthritis Undergoing Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Citalopram
  • Sponsor:Sygehus Lillebaelt Vejle Sygehus

Haematological malignancy+1

Not yet recruiting

Study on the Safety and Effectiveness of Pembrolizumab, Favezelimab, and Vibostolimab for Children and Young Adults with Blood Cancers or Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Chronic kidney disease

Not yet recruiting

Study on the Effects of Finerenone, Dapagliflozin, and Ambrisentan in Patients with Chronic Kidney Disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ambrisentan
  • Sponsor:Steno Diabetes Center Copenhagen

Type IIa hyperlipidaemia

Not yet recruiting

Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide Chloride
  • Sponsor:Merck Sharp & Dohme LLC

Glioblastoma

Not yet recruiting

Study on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Carthera

Ischaemic stroke

Not yet recruiting

Study on Imatinib for Improving Recovery in Patients with Acute Ischemic Stroke

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Karolinska Institutet

Coma

Not yet recruiting

Study on Psilocybin and Apomorphine for Improving Consciousness in Patients with Coma and Brain Injury

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Hovedstaden

Breast cancer

Not yet recruiting

Study on the Effectiveness of Ropivacaine Hydrochloride, Anhydrous Lidocaine Hydrochloride, and Alfentanil for Patients Undergoing Minor Breast Cancer Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Anhydrous Lidocaine Hydrochloride
  • Sponsor:Region Sjaelland

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hellerup

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular diseases including studies of new treatments for heart failure, atrial fibrillation, and atherosclerosis.

  • Heart failure treatment optimization
  • Stroke prevention strategies
  • Hypertension management

Current research examines novel therapeutic approaches like colchicine for heart conditions and innovative anticoagulation treatments.

02 Metabolic Disorders

Comprehensive studies addressing obesity and weight management through innovative therapeutic approaches and lifestyle interventions.

  • Weight reduction treatments
  • Diabetes management
  • Metabolic health optimization

Multiple trials are evaluating new medications including CagriSema and dapiglutide for weight management.

03 Respiratory Medicine

Advanced research in respiratory diseases including studies on vaccines and treatments for various pulmonary conditions.

  • Influenza prevention
  • COPD management
  • Pulmonary fibrosis treatments

Investigations include innovative approaches to lung disease treatment and prevention strategies.

04 Dermatological Studies

Clinical research focusing on skin conditions including treatments for psoriasis and atopic dermatitis.

  • Psoriasis therapies
  • Hidradenitis suppurativa treatment
  • Innovative dermatological interventions

Studies evaluate new biological treatments and their effectiveness in chronic skin conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.